In 2025, U.S. healthcare once again finds itself at the center of heated debate. The Ivermectin debate and U.S. healthcare reforms 2025 highlight deep divisions in public trust, medical guidance, and federal policy. Recent CDC shakeups in vaccine recommendations have reignited old disputes, forcing both policymakers and patients to reconsider the boundaries between...